2 minute read
Nov. 26, 2021

ETX0462: A Broad-Spectrum Beta-Lactamase Inhibitor with Single-Agent Activity

ETX0462

penicillin-binding protein + β-lactamase inh. preclin. eff. at 50 mpk SC, 2,000 mpk tolerated multitarget SBDD + opt. for porin permeability Nature Entasis Therapeutics

twitterlinkedinprintemail